|
|
|
26.11.25 - 09:09
|
DAX überspringt GD200 – Allianz, Aroundtown, Heidelberg Materials, Nemetschek, Renk, Sartorius im Check (Der Aktionaer)
|
|
|
Beflügelt von der Hoffnung auf einen Frieden in der Ukraine und neuen Zinssenkungsfantasien ist der DAX am Vortag um rund ein Prozent gestiegen und damit beinahe über die wichtige 200-Tage-Linie. Das gelingt dem deutschen Leitindex zum Handelsstart, wobei Unternehmen wie Allianz, Aroundtown, Heidelberg Materials, Nemetschek, Renk und Sartorius im Fokus stehen....
|
|
|
|
|
|
|
|
|
|
|
21.11.25 - 11:00
|
Alvotech and Advanz announce EC approval for Gobivaz biosimilar (PBR)
|
|
|
The authorisations cover Gobivaz in both 100mg/ml and 50mg/0.5ml formulations, provided in pre-filled syringes with autoinjector formats and passive needle safety guards, to treat adults with axial spondyloarthritis,
The post Alvotech and Advanz announce EC approval for Gobivaz biosimilar appeared first on Pharmaceutical Business review....
|
|
|
20.11.25 - 23:15
|
AM Best Affirms Credit Ratings of Auna Seguros, S.A. (Business Wire)
|
|
|
MEXICO CITY--(BUSINESS WIRE)--#insurance--AM Best has affirmed the Financial Strength Rating of B++ (Good), the Long-Term Issuer Credit Rating of “bbb” (Good) and the Mexico National Scale Rating of “aa.MX” (Superior) of Auna Seguros, S.A. (Auna Seguros) (formerly Dentegra Seguros Dentales S.A.) (Mexico). The outlook of these Credit Ratings (ratings) is stable.
The ratings reflect Auna Seguros' balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ERM).
Auna Seguros is a dental insurance company, which initiated operations in Mexico in 2007, and successfully implemented its growth strategy to achieve its break-even point within five years. The company continues to be ranked as a market leader, holding over a 60% share of Mexico's dental insurance market. Auna Seguros operates through a network of independent agents, local brokers and other insurance companies as a compleme...
|
|
|
|
|
20.11.25 - 22:51
|
Auna Announces 3Q25 Financial Results (Business Wire)
|
|
|
Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in MexicoLUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 (“third quarter 2025” or “3Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted.
3Q25 Consolidated Highlights
Consolidated Revenue increased 1% FXN, while decreasing 1% YoY on reported basis, to S/1,117 million
Adjusted EBITDA decreased 5% FXN, or 7% YoY on reported basis, to S/232 million
Adjusted EBITDA Margin of 20.8%, down 1.3 p.p. YoY from 22.1%
Adjusted Net Income was S/58 million, down from S/75 million in 3Q24
Leverage Ratio remains unchanged at 3.6x
Mexico's surgeries and oncolo...
|
|
|
|
|
20.11.25 - 10:06
|
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab) (GlobeNewswire EN)
|
|
|
REYKJAVIK, Iceland and LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Commission (EC) has granted marketing authorizations in the European Economic Area (EEA) for Gobivaz®, Alvotech's biosimilar to Simponi® (golimumab)....
|
|
|
|
|
|
|
14.11.25 - 14:36
|
ANLEIHEN-Woche #KW46 – 2025: Schalke 04, paragon, TIN INN, Mutares, IMMOVATION, Noratis, PANDION, Energiekontor, UBM, Formycon, TPG, Dt. Rohstoff, PNE, FCR, MS Industrie, PCC, Eleving, Photon Energy, reconcept, … (Anleihen-Finder)
|
|
|
ANLEIHEN-Woche #KW46 – 2025: Schalke 04, paragon, TIN INN, Mutares, IMMOVATION, Noratis, PANDION, Energiekontor, UBM, Formycon, TPG, Dt. Rohstoff, PNE, FCR, MS Industrie, Eleving, Photon Energy, reconcept, ...
Der Beitrag ANLEIHEN-Woche #KW46 – 2025: Schalke 04, paragon, TIN INN, Mutares, IMMOVATION, Noratis, PANDION, Energiekontor, UBM, Formycon, TPG, Dt. Rohstoff, PNE, FCR, MS Industrie, PCC, Eleving, Photon Energy, reconcept, … erschien zuerst auf Anleihen-Finder.de....
|
|
|
|
|
|
|
13.11.25 - 06:09
|
TAGESVORSCHAU: Termine am 13. November 2025 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Donnerstag, den 13. November 2025^TERMINE UNTERNEHMEN06:30 DEU: Formycon, Q3-Zahlen06:45 LUX: Grand City Properties, Q3-Zahlen07:00 AUT: Wienerberger, Q3-Zahlen07:00 ......
|
|
|
|
|
12.11.25 - 22:45
|
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update (GlobeNewswire EN)
|
|
|
REYKJAVIK, Iceland, November 12, 2025 - Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first nine months of 2025 and provided a summary of recent pipeline and corporate highlights. Management will conduct a conference call and live audio webcast on November 13, 2025, at 8:00 am ET (13:00 GMT / 14:00 CET)....
|
|
|
12.11.25 - 17:42
|
TAGESVORSCHAU: Termine am 13. November 2025 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Donnerstag, den 13. November 2025^TERMINE UNTERNEHMEN06:30 DEU: Formycon, Q3-Zahlen06:45 LUX: Grand City Properties, Q3-Zahlen07:00 AUT: Wienerberger, Q3-Zahlen07:00 ......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
